Regulatory Pharma NetRegulatory Pharma Net, regulatory affairs pharma.#Regulatory #affairs #pharma


Posted On Jun 12 2018 by

regulatory affairs pharma

Regulatory affairs pharma

  • Regulatory affairs pharmaRegulatory affairs pharmaRegulatory affairs pharma

OUR GOAL IS TO EXCEED YOUR EXPECTATIONS

Regulatory affairs pharma

Regulatory affairs pharma

Regulatory affairs pharma

OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing Reimbursement, Market Access

Regulatory affairs pharma

Global and Local Regulatory Affairs

Regulatory affairs pharma

Strategic Advice and Due Diligence

Regulatory affairs pharma

Pricing & Reimbursement and Market Access

Regulatory affairs pharma

Pharmacovigilance

Regulatory affairs pharma

eCTD and Regulatory Procedures Management

Regulatory affairs pharma

Medical Devices

Regulatory affairs pharma

Project Management

Regulatory affairs pharma

Orphan Drug Applications

Regulatory affairs pharma

Pharmaceutical, Preclinical and Clinical Development

Regulatory affairs pharma

Clinical Trial Applications

Regulatory affairs pharma

Quality Management and Auditing

Regulatory affairs pharma

Scientific / Medical Writing

Regulatory affairs pharma

Product Information and Readability Testing

Regulatory affairs pharma

Life Cycle Management

Regulatory affairs pharma

Training

Regulatory affairs pharma

Biocides, Food Supplements and Cosmetics

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

EVENTS

Discover next events

Regulatory affairs pharma

NEW LEGISLATION ABOUT COMPASSIONATE USE IN.

The new legislation about “Discipline of the therapeutic use of an investigational medicinal product” (Ministerial Decree Sept.

Regulatory affairs pharma

NEW EUDRAVIGILANCE VERSION: IMPACT ON THE .

On November 22nd, 2017 EMA will launch a new and improved version of EudraVigilance. This will have impact also to the Italian .

Regulatory affairs pharma

REGULATORY PHARMA NET EXHIBITS AT ISPOR 20.

RPN will exhibit at ISPOR 20TH Annual European Congress that will be held at the Scottish Event Campus (SEC), Glasgow, Scotland�.

Regulatory affairs pharma

Some useful links are here available.

Regulatory affairs pharma

CERTIFICATIONS

Regulatory affairs pharma

CAREERS

Would you like to work with us?

We look forward to receiving your application and meeting you

CONTACT US

Our experts are available to help you with any question you might have

Regulatory affairs pharma

Corso Italia, 108 – 56125 Pisa Italy

Phone: +39 050 503 954 / 500 785 – Fax: +39 050 220 4315

E-mail: [email protected] / Mail PEC: [email protected]

VAT number: 02263880482 – Pisa REA business registry: n. 142208 – Corporation stock: € 15.600 i.v.

Privacy

If you wish to contact us please read the information notice below and then check on the box at the bottom of the contact form. By checking you consent in accordance with Section 23 of Italian PDPA.

This information notice is provided pursuant to Section 13 of the Italian Legislative Decree No. 196/2003, as amended (the “Italian PDPA”) and applies to personal data voluntarily provided by users (“Data Subjects”) who use the “Contact Us” form (“Form”) of the company website www.regulatorypharmanet.com (“Site”).

The Company may process personal data that you provided via the Form for the sole purpose of processing your requests and/or enquiries (including but not limited to, requests for technical assistance and information). Where marked, personal data are necessary for the Company to process your requests and/or enquiries or to contact you to follow up your queries. Refusal to provide data marked will prevent the Company from providing the services you may have requested.

You may at any times exercise the rights established by Section 7 of the Italian PDPA, including your right to receive confirmation of the existence of your personal data within the Company, your right to check the content, the source and the accuracy of your data, and/or to request that your data are updated, erased and/or de-identified, if unlawfully processed, as well as your right to stop the processing of your data for any legitimate reasons. At any times you may apply the Data Controller sending and e-mail to [email protected]

To receive information on the processing of your personal data by the Company, to exercise the rights established by the Italian PDPA, as well as to receive the updated list of subjects to whom data are accessible.

The Data Controller is Regulatory Pharma Net Srl (“Company”), with registered offices in Corso Italia 108, 56125, Pisa, Italy.

Having read the above, you authorize the processing and communication of personal data to Regulatory Pharma Net Srl and the companies related to it.

Regulatory affairs pharma


Last Updated on: June 12th, 2018 at 8:00 am, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *